Omega-3 fatty acids (EPA and DHA) markedly suppressed monocyte rolling and adherence on activated endothelial cells in vitro by inhibiting endothelial platelet-activating factor (PAF) generation.
Does preincubation with EPA or DHA reduce monocyte rolling and adhesion to activated human endothelial cells in vitro?
Omega-3 fatty acids suppress monocyte rolling and adherence on activated endothelial cells in vitro by inhibiting endothelial PAF generation.
Monocyte-endothelium interaction is a fundamental process in many acute and chronic inflammatory diseases. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are fish oil-derived alternative (omega-3) precursor fatty acids implicated in the suppression of inflammatory events. We investigated their influence on rolling and adhesion of monocytes to human umbilical vein endothelial cells (HUVEC) under laminar flow conditions in vitro. Exposure of HUVEC to tumor necrosis factor (TNF-alpha) strongly increased 1) surface expression of intercellular adhesion molecule (ICAM-1), vascular cell adhesion molecule (VCAM-1), and E-selectin, 2) platelet-activating factor (PAF) synthesis as assessed by thrombin challenge, and 3) rate of rolling and adhesion of monocytes. Preincubation of HUVEC with EPA or DHA markedly suppressed PAF synthesis, monocyte rolling, and adherence, whereas expression of endothelial adhesion molecules was unchanged. Also, PAF receptor antagonists markedly suppressed the adhesion rate of monocytes, and EPA or DHA revealed no additional inhibitory capacity. In contrast, arachidonic acid partially reversed the effect of the antagonist. We conclude that omega-3 fatty acids suppress rolling and adherence of monocytes on activated endothelial cells in vitro by affecting endothelial PAF generation.
Mayer et al. (Thu,) reported a other. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) was evaluated on Monocyte rolling and adhesion to HUVEC, and PAF synthesis. Omega-3 fatty acids (EPA and DHA) markedly suppressed monocyte rolling and adherence on activated endothelial cells in vitro by inhibiting endothelial platelet-activating factor (PAF) generation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: